These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 15085979)

  • 21. Safety of IBI-10090 for inflammation associated with cataract surgery: Phase 3 multicenter study.
    Donnenfeld ED; Solomon KD; Matossian C
    J Cataract Refract Surg; 2018 Oct; 44(10):1236-1246. PubMed ID: 30139638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of 0.1% dexamethasone phosphate eye gel (Dexagel) and 1% prednisolone acetate eye suspension in the treatment of post-operative inflammation after cataract surgery.
    Struck HG; Bariszlovich A
    Graefes Arch Clin Exp Ophthalmol; 2001 Oct; 239(10):737-42. PubMed ID: 11760033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase II results of an intraocular steroid delivery system for cataract surgery.
    Chang DF; Garcia IH; Hunkeler JD; Minas T
    Ophthalmology; 1999 Jun; 106(6):1172-7. PubMed ID: 10366088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of peroperative subconjunctival injection of methylprednisolone and standard postoperative steroid drops after uneventful cataract surgery.
    Merkoudis N; Wikberg Matsson A; Granstam E
    Acta Ophthalmol; 2014 Nov; 92(7):623-8. PubMed ID: 24479722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical comparison of two topical prednisolone acetate 1% formulations in reducing inflammation after cataract surgery.
    Raizman MB; Donnenfeld ED; Weinstein AJ
    Curr Med Res Opin; 2007 Oct; 23(10):2325-31. PubMed ID: 17697456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of 0.4% ketorolac tromethamine ophthalmic solution versus 0.5% ketorolac tromethamine ophthalmic solution after phacoemulsification and intraocular lens implantation.
    Sandoval HP; De Castro LE; Vroman DT; Solomon KD
    J Ocul Pharmacol Ther; 2006 Aug; 22(4):251-7. PubMed ID: 16910866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and tolerability of a gatifloxacin/prednisolone acetate fixed combination for topical prophylaxis and control of inflammation in phacoemulsification: a 20-day-double-blind comparison to its individual components.
    Cunha PA; Shinzato FA; Tecchio GT; Weber SL; Brasil A; Avakian A
    Clinics (Sao Paulo); 2013 Jun; 68(6):834-9. PubMed ID: 23778476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A double-masked, placebo-controlled evaluation of 0.5% loteprednol etabonate in the treatment of postoperative inflammation. The Loteprednol Etabonate Postoperative Inflammation Study Group 2.
    Ophthalmology; 1998 Sep; 105(9):1780-6. PubMed ID: 9754192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the efficacy and safety of two formulations of diclofenac sodium 0.1% eyedrops in controlling postoperative inflammation after cataract surgery.
    Bodaghi B; Weber ME; Arnoux YV; Jaulerry SD; Le Hoang P; Colin J
    Eur J Ophthalmol; 2005; 15(6):702-11. PubMed ID: 16329054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the Effect of Diclofenac 0.1% and Nepafenac 0.1% on Aqueous Flare in Patients Undergoing Cataract Surgery: A Prospective Randomized Study.
    Cagini C; Pellegrino A; Cerquaglia A; Iaccheri B; Lupidi M; Fiore T
    Curr Eye Res; 2020 Sep; 45(9):1089-1093. PubMed ID: 32004437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes of congenital cataract surgery: intraoperative intracameral triamcinolone injection versus postoperative oral prednisolone.
    Ventura MC; Ventura BV; Ventura CV; Ventura LO; Arantes TE; Nosé W
    J Cataract Refract Surg; 2014 Apr; 40(4):601-8. PubMed ID: 24530023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dexamethasone Intracameral Drug-Delivery Suspension for Inflammation Associated with Cataract Surgery: A Randomized, Placebo-Controlled, Phase III Trial.
    Donnenfeld E; Holland E
    Ophthalmology; 2018 Jun; 125(6):799-806. PubMed ID: 29397189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized clinical trial of Surodex steroid drug delivery system for cataract surgery: anterior versus posterior placement of two Surodex in the eye.
    Tan DT; Chee SP; Lim L; Theng J; Van Ede M
    Ophthalmology; 2001 Dec; 108(12):2172-81. PubMed ID: 11733254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A pharmacoeconomic analysis of rimexolone for the treatment of ophthalmic inflammatory conditions.
    Halpern MT; Palmer CS; Foster S; Pal A; Battista C
    Am J Manag Care; 1998 Jun; 4(6):854-62. PubMed ID: 10181071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A single intraoperative sub-tenon's capsule injection of triamcinolone and ciprofloxacin in a controlled-release system for cataract surgery.
    Paganelli F; Cardillo JA; Melo LA; Lucena DR; Silva AA; Oliveira AG; Höfling-Lima AL; Nguyen QD; Kuppermann BD; Belfort R;
    Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3041-7. PubMed ID: 19234342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of topical ketorolac 0.4%, nepafenac 0.1%, and bromfenac 0.09% on postoperative inflammation using laser flare photometry in patients having phacoemulsification.
    Sahu S; Ram J; Bansal R; Pandav SS; Gupta A
    J Cataract Refract Surg; 2015 Oct; 41(10):2043-8. PubMed ID: 26703278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative effects of ketorolac 0.5% or diclofenac 0.1% ophthalmic solutions on inflammation after cataract surgery.
    Flach AJ; Dolan BJ; Donahue ME; Faktorovich EG; Gonzalez GA
    Ophthalmology; 1998 Sep; 105(9):1775-9. PubMed ID: 9754191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of topical diclofenac with prednisolone for postcataract inflammation.
    Roberts CW; Brennan KM
    Arch Ophthalmol; 1995 Jun; 113(6):725-7. PubMed ID: 7786212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [0.1% dexamathasone and 1% rimexolone. A comparative study in the postoperative treatment after cataract extraction].
    Vico-Ruiz E; Benítez-Del-Castillo-Sánchez JM; Cuiña-Sardiña R; Martínez-De-La-Casa JM; García-Sánchez J
    Arch Soc Esp Oftalmol; 2009 Jun; 84(6):299-304. PubMed ID: 19568990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bromfenac ophthalmic solution 0.07% dosed once daily for cataract surgery: results of 2 randomized controlled trials.
    Walters TR; Goldberg DF; Peace JH; Gow JA;
    Ophthalmology; 2014 Jan; 121(1):25-33. PubMed ID: 24021896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.